The S&P 500 is likely to keep rising sharply and gain more than 30 percent from present-day highs, leading to a potential stock market bubble and subsequent meltdown, Sarasin Bank's chief strategist warned.
TheStreet.com reports its investor predictions for FDA drug approvals in 2013: Bad news for Arena Pharmaceuticals, Delcath Systems and Aveo Pharmaceuticals, but Sarepta Therapeutics and Ziopharm are among the winners.
General Electric has made tremendous progress over the past few years and the increase in the company's share price has led to a downgrade by Nomura Securities analyst.
The brightening U.S. economy is lifting the dollar, but this expert says certain dollar trades will do better than others. Hint: look for central bank stimulus.
The most important number for COMEX gold is $1,540 an ounce. This has determined the precious metal's course in the past and could do so going forward.
The airline business is finally a profitable one because the carriers have brought down their capacity. They've done it by stripping out flights and replacing larger planes on many routes with smaller regional jets.
Following the recent jump in Best Buy's stock price, Piper Jaffray upgraded the company's shares to "overweight" in a report that de-emphasized "showrooming" as a threat to the consumer electronics retailer.